{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"150"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"}],"units":"Participants"}],"description":"Determination of dosage for expansion cohort in Part B. Dosage was the MTD or less depending on tolerability.","groups":[{"description":"Patients receiving oral administration of afatinib film-coated tablet once daily for three days, repeated every 14 days, during each 28-day cycle.","id":"OG000","title":"Afatinib"}],"paramType":"NUMBER","populationDescription":"Treated set including patients eligible for MTD determination","reportingStatus":"POSTED","timeFrame":"28 days","title":"Determination of Dosage for Expansion Cohort in Part B","type":"SECONDARY","unitOfMeasure":"mg"}